Predictors of Durable Hepatitis B Surface Antigen Loss After Pegylated Interferon–Based Therapy in Patients with Hepatitis B e Antigen–Negative Chronic Hepatitis B: A Multicenter Real-World Study
HBsAb at end of treatment and Peg-IFNα consolidation therapy time are potential predictors of durable HBsAg loss.
Authors
- Lihua Duan (ORCID: https://orcid.org/0000-0002-1631-4675)
- Min Tan (ORCID: https://orcid.org/0000-0002-1986-8438)
- Zhiliang Gao
- Xuexuan Li (ORCID: https://orcid.org/0009-0009-7731-4271)
- Yongwen Yang (ORCID: https://orcid.org/0000-0001-8824-6512)
- Yan Huang (ORCID: https://orcid.org/0000-0002-3151-5555)
- Zebing Huang (ORCID: https://orcid.org/0000-0002-3403-8758)
- Shang Gao (ORCID: https://orcid.org/0009-0009-5638-6110)
- Jun Chen (ORCID: https://orcid.org/0000-0002-0973-2051)
- Xueyao Yang
Institutions
- Central South University (CN)
- Sun Yat-sen University (CN)
- National Clinical Research (US)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- Hepatitis B Foundation (US)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-04-24
- DOI
- https://doi.org/10.1093/infdis/jiaf198
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
- Key Research and Development Program of Hunan Province of China